James Whitaker, DO
Physical Medicine & Rehabilitation · Boise, IDNPI 1750692562
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 42.4% of the total. Among physical medicine & rehabilitation clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 223 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$440
- Amgen$368
- Teva Pharmaceuticals USA, Inc.$364
- Collegium Pharmaceutical, Inc.$202
- Pfizer$176
- plus $968 from 19 others
What the payments were for
- Food & beverage$4,370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $1,853 |
| Lilly USA, LLC | 29 | $440 |
| Amgen | 18 | $368 |
| Teva Pharmaceuticals USA, Inc. | 22 | $364 |
| Collegium Pharmaceutical, Inc. | 13 | $202 |
| Pfizer | 12 | $176 |
| Upsher-smith Laboratories LLC | 9 | $174 |
| Boston Scientific | 2 | $173 |
| Nevro Corp. | 2 | $124 |
| Biodelivery Sciences International, Inc. | 5 | $78 |
| Stimwave Technologies Incorporated | 1 | $72 |
| Abbott | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Fidia Pharma USA Inc. | 2 | $26 |
| Johnson & Johnson | 1 | $25 |
| Medtronic | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,370 in reported general payments places this provider in the 90th percentile of 38 physical medicine & rehabilitation providers in Idaho.
See all physical medicine & rehabilitation providers in Idaho →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 28 | $9,004 |
| Pregabalin | 144 | $6,341 |
| Xtampza ErOxycodone Myristate | 12 | $5,716 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 216 | $4,577 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 134 | $3,710 |
| Oxycodone Hcl | 128 | $2,535 |
| Gabapentin | 94 | $1,810 |
| Fentanyl | 11 | $1,711 |
| Tramadol Hcl | 126 | $1,400 |
| Naloxone Hcl | 12 | $885 |
| Tizanidine Hcl | 71 | $647 |
| Duloxetine Hcl | 38 | $635 |
| Buprenorphine Hcl | 21 | $598 |
| Meloxicam | 115 | $357 |
| Morphine Sulfate | 16 | $352 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $202 | $5,71612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 38 physical medicine & rehabilitation providers in Idaho.
Other physical medicine & rehabilitation in Boise
- Robert FriedmanBoise$18K
- Carolyn BlaschBoise$751
- Monte MooreBoise$535
- Brooke HergertBoise$303
- Nancy GreenwaldBoise$163
- Vic KadyanBoise$126
- Nathan TruexBoise$85
- Lynn ShenkBoise$62
- Rodde CoxBoise$0
- Kevin KrafftBoise$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.